Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Medical Device Manufactures Gambling on New Guarantee Strategy for U.S. Hospitals

By Pharmaceutical Processing | September 17, 2015

New product guarantees for U.S. hospitals may put medical device manufacturers at risk of losing profits, as companies may have to pay for follow-up treatments should their products not work as expected, says an analyst with research and consulting firm GlobalData.

According to Wenlu Hu, GlobalData’s Analyst covering Medical Devices, this new marketing strategy will be mutually beneficial in the short term, as it will help manufacturers who are struggling with decreasing demand for their products, while offering quality reassurance and financial risk-sharing of procedures for healthcare providers.

However, in the long term, device manufacturers may see their profits disappear, as they could have to pay for patients’ subsequent treatments.

Hu explains: “Faced with a difficult economic climate and the medical device excise tax, which is unlikely to be repealed, there is an urgent need for device makers to demonstrate the cost-effectiveness of their products and services in order to gain a competitive edge in the marketplace.

“However, offering an extended guarantee will not reduce the likelihood of patient lawsuits over faulty products, which have been on the rise in recent years.  Furthermore, hospitals may seek even more robust performance guarantees from device makers when this marketing strategy becomes more common, at which point manufacturers may find themselves in a profit-losing situation.”

While it remains unclear how many hospitals have signed up for the new guarantees, companies such as Medtronic, Johnson & Johnson (J&J), and St. Jude Medical have all become amongst the first to offer such promises. Manufacturers of hip and knee implants have also indicated an interest in providing similar guarantees.

“Overall, this marketing strategy indicates that evidence-based and risk-sharing healthcare is becoming increasingly important, as device makers are practically required to take on additional risks to gain sales and reassure healthcare providers of the quality of their products,” the analyst concludes.

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE